BEGIN:VCALENDAR VERSION:2.0 PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:The BioCalendar X-ORIGINAL-URL:https://thebiocalendar.com X-WR-CALDESC:Events for The BioCalendar REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20270314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20271107T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20260511 DTEND;VALUE=DATE:20260516 DTSTAMP:20260530T230104 CREATED:20251206T101044Z LAST-MODIFIED:20251206T101044Z UID:9623-1778457600-1778889599@thebiocalendar.com SUMMARY:ASGCT Annual Meeting DESCRIPTION:The ASGCT Annual Meeting is the leading global event for professionals in gene and cell therapy\, hosted by the American Society of Gene + Cell Therapy (ASGCT) to showcase cutting-edge research\, new technologies\, and clinical applications\, offering crucial networking for scientists\, industry leaders\, and clinicians to advance treatments for human diseases. It features expert presentations\, novel abstract presentations\, workshops\, and exhibitions from companies in the cell and gene therapy ecosystem. URL:https://thebiocalendar.com/event/asgct-annual-meeting/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Academic Research,Networking,Presentation END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260511 DTEND;VALUE=DATE:20260516 DTSTAMP:20260530T230104 CREATED:20251206T101440Z LAST-MODIFIED:20260116T121409Z UID:9625-1778457600-1778889599@thebiocalendar.com SUMMARY:PEGS Boston DESCRIPTION:The PEGS Boston Summit is where the future of biologics takes shape. For over 20 years\, PEGS is the go-to event for protein and antibody engineering\, drug development\, immunotherapy\, radiotherapy\, and AI/ML-driven biologics research. New in 2026: a dedicated focus on peptides\, spotlighting their therapeutic power\, design innovations\, and expanding role in drug discovery. \nWith 350+ presentations\, breakout sessions\, and interactive training seminars\, PEGS delivers the insights and connections you need to stay ahead. The exhibit hall buzzes with top technology and service providers\, giving you a front-row seat to the tools transforming the industry. \nDon’t just follow the science – be part of it. Join us at the 2026 PEGS Boston Summit and connect with the leaders shaping what’s next in biologics and beyond. URL:https://thebiocalendar.com/event/pegs-boston-3/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Featured,Summit ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/pegs2026-scaled.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260511T080000 DTEND;TZID=America/Los_Angeles:20260514T170000 DTSTAMP:20260530T230104 CREATED:20251206T100827Z LAST-MODIFIED:20251206T100827Z UID:9622-1778486400-1778778000@thebiocalendar.com SUMMARY:AAPS National Biotechnology Conference DESCRIPTION:The AAPS National Biotechnology Conference (NBC) is a premier annual event by the American Association of Pharmaceutical Scientists (AAPS) for leaders in pharma and biotech to explore cutting-edge science in biologics\, advanced therapies\, and innovative drug development\, focusing on new modalities like CAR-T\, gene therapies\, and AI in drug discovery\, bridging research from lab to patient. It features scientific sessions\, poster presentations\, and networking opportunities\, addressing challenges in formulation\, bioanalysis\, manufacturing\, and translational science for complex drugs URL:https://thebiocalendar.com/event/aaps-national-biotechnology-conference/ LOCATION:San Diego\, San Diego\, CA\, United States CATEGORIES:Academic Research,Summit,Symposium END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260512 DTEND;VALUE=DATE:20260515 DTSTAMP:20260530T230104 CREATED:20260330T202508Z LAST-MODIFIED:20260330T202508Z UID:10116-1778544000-1778803199@thebiocalendar.com SUMMARY:Fierce Biotech Week DESCRIPTION:Be in the Room Where Decisions Are Made \n\n\n\n\n\n\n\n\nFierce Biotech Week attracts senior leaders across biotech and pharma\, including: \n\n\nC-suite executives and founders \n\n\nHeads of R&D and Drug Development \n\n\nClinical & TMF leadership \n\n\nBD&L and corporate strategy teams \n\n\nPR & Communications executives \n\n\nStrategic outsourcing partners \n\n\nThis is not a spectator audience. It’s a room of decision-makers. URL:https://thebiocalendar.com/event/fierce-biotech-week-2/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260514T110000 DTEND;TZID=America/Los_Angeles:20260514T120000 DTSTAMP:20260530T230104 CREATED:20260409T125450Z LAST-MODIFIED:20260409T125450Z UID:10176-1778756400-1778760000@thebiocalendar.com SUMMARY:AI Meets Informed Consent: Opportunity\, Risk\, and What IRBs Need to See DESCRIPTION:The informed consent process is an ongoing dialogue that helps participants decide\, with full understanding\, whether to take part in a clinical trial. As generative AI begins to influence how consent documents are created\, translated\, and delivered\, this process is becoming more complex. \nJoin experts in IRB oversight\, research ethics\, and health literacy to explore the opportunities and challenges of AI-assisted informed consent. This session will cover ethical foundations\, emerging use cases for generative AI\, and what sponsors and CROs need to communicate to IRBs when using these tools. \nDesigned for clinical operations leaders across biopharma\, medtech\, and CROs\, this discussion will provide a practical framework for evaluating AI-driven consent approaches while keeping patient understanding and protection at the center. URL:https://thebiocalendar.com/event/ai-meets-informed-consent-opportunity-risk-and-what-irbs-need-to-see/ ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-14-26-Brany-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260514T110000 DTEND;TZID=America/Los_Angeles:20260514T120000 DTSTAMP:20260530T230104 CREATED:20260416T190955Z LAST-MODIFIED:20260416T190955Z UID:10214-1778756400-1778760000@thebiocalendar.com SUMMARY:Strategic Early Material Generation for Accelerated Process Development DESCRIPTION:Accelerate biologics development by enabling rapid access to scalable\, production-relevant early-stage material that supports developability assessment and process optimization. This webinar highlights Samsung Biologics’ integrated approach\, aligning material generation with cell line development\, incorporating early optimization\, and leveraging stable expression platforms to deliver consistent\, high-quality material with reduced variability. Learn how this streamlined strategy shortens timelines\, simplifies processes\, and improves resource efficiency\, supported by case studies demonstrating successful scale-up from flask to bioreactor. \nKey Takeaways:\n– The role of early material generation in enabling efficient biologics development and early developability assessment\n– How aligning material generation with cell line development supports both speed and scalability from early stages\n– How scalable\, production-relevant material supports process development activities\, including formulation studies and other material-intensive applications\, while improving overall time and resource efficiency URL:https://thebiocalendar.com/event/strategic-early-material-generation-for-accelerated-process-development/ ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-14-26-Samsung-eblast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260514T110000 DTEND;TZID=America/Los_Angeles:20260514T120000 DTSTAMP:20260530T230104 CREATED:20260429T123708Z LAST-MODIFIED:20260429T123708Z UID:10280-1778756400-1778760000@thebiocalendar.com SUMMARY:Understanding the Regulatory Landscape for Ophthalmic Drug Products: Contamination Control Strategies\, USP \, and Purpose-Built Solutions DESCRIPTION:Ophthalmic drugs face strict regulations\, including USP limits on particulate matter and updated EU GMP Annex 1 requirements for comprehensive Contamination Control Strategies (CCS). These standards emphasize minimizing contamination across packaging\, sterilization\, and system controls. \nThis webinar explores how these regulations impact real-world development challenges and how purpose-built packaging—featuring low particulates\, silicone-free designs\, and advanced barrier technologies—can support compliance\, improve dose accuracy\, and reduce risk. \nYou’ll learn:\n– The role of CCS in reducing contamination risks\n– Key regulatory requirements\, including USP\n– Common challenges like particulates\, silicone oil\, and endotoxins\n– Packaging solutions for safer ophthalmic drug delivery \nKey takeaways:\n– Build an effective CCS\n– Understand ophthalmic vs. injectable requirements\n– Interpret USP limits\n– Evaluate solutions for compliant drug delivery URL:https://thebiocalendar.com/event/understanding-the-regulatory-landscape-for-ophthalmic-drug-products-contamination-control-strategies-usp-and-purpose-built-solutions-2/ ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-14-26-West-eBlast-700x200-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260514T110000 DTEND;TZID=America/Los_Angeles:20260514T120000 DTSTAMP:20260530T230104 CREATED:20260429T123929Z LAST-MODIFIED:20260429T123929Z UID:10284-1778756400-1778760000@thebiocalendar.com SUMMARY:Strategic Early Material Generation for Accelerated Process Development DESCRIPTION:Rapid access to early-stage material is critical for biologics development\, especially as molecular complexity increases and timelines expand. Generating scalable\, high-quality material early helps streamline developability assessments and process development. \nIn this webinar\, Samsung Biologics presents its strategy for early material generation\, integrating it with cell line development (CLD)\, early optimization\, and stable expression platforms. This approach delivers consistent\, production-relevant material—nearly equivalent to single-clone sources—while reducing variability\, time\, and complexity. \nLearn how this streamlined workflow accelerates development from sequence to material\, supports downstream activities\, and improves efficiency. Case studies will highlight scalable production from flask to bioreactor and the impact of early decisions on timelines and costs. \nKey benefits:\n– Faster\, more efficient early-stage biologics development\n– Improved scalability through alignment with CLD\n– Reliable material supply for process and formulation studies URL:https://thebiocalendar.com/event/strategic-early-material-generation-for-accelerated-process-development-2/ ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-14-26-Samsung-eblast-700x200-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260514T170000 DTEND;TZID=America/Los_Angeles:20260514T190000 DTSTAMP:20260530T230104 CREATED:20260504T223230Z LAST-MODIFIED:20260504T223230Z UID:10344-1778778000-1778785200@thebiocalendar.com SUMMARY:Launching the Future of Leadership in Our Community DESCRIPTION:LiB Bay Area Regional Ambassador Pilot kicks off May 14 at Genentech\, connecting life sciences professionals & local members. \n\n\n\n\nJoin Latinos in Bio for the Bay Area kickoff of our Regional Ambassador Pilot\, an initiative to grow our West Coast presence and connect Latinx life sciences professionals. \nThis special evening\, hosted in partnership with Genentech\, will combine casual networking with a brief introduction to LiB. Meet LiB leadership\, connect with fellow members\, and learn how the Regional Ambassador Pilot will foster a thriving Bay Area community. URL:https://thebiocalendar.com/event/launching-the-future-of-leadership-in-our-community/ LOCATION:South San Francisco\, CA\, CA\, 94080\, United States CATEGORIES:Networking END:VEVENT END:VCALENDAR